
M Regina Castro MD FACE (She/Her)
Diabetes, Thyroid
Professor of Medicine Div of Endocrinology and Metabolism Director, Endocrinology fellowship program director, Mayo Clinic, Rochester, MN
Join to View Full Profile
200 1st Street SWRochester, MN 55905
Dr. Castro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. M Regina Castro is an endocrinologist at Mayo Clinic, Rochester, MN where she is Director of the Endocrinology fellowship program. She received her MD from Central Univ of Venezuela and has been in practice >30 years. She speaks Spanish and French. She specializes in thyroid disorders, and diabetes, and is an expert in thyroid cancer, thyroid neoplasms, thyroid disease, and thyroid FNA
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1993 - 1996
- Central University of VenezuelaClass of 1987
Certifications & Licensure
- MN State Medical License 1996 - 2025
- PA State Medical License 1994 - 1996
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Outcomes of Radiofrequency Ablation for Autonomously Functioning Thyroid Adenomas-Mayo Clinic Experience.Maheswaran Dhanasekaran, John Schmitz, Maria Regina Castro, Aadil Rajwani, Robert Alan Lee
Journal of the Endocrine Society. 2024-10-29 - 3 citationsPatient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study.Chandani Patel Patel Chavez, Eddison Godinez Leiva, Diliara Bagautdinova, Jessica Hidalgo, Sandra Hartasanchez
Endocrine. 2023-04-01 - 18 citationsRadiofrequency Ablation of Benign and Malignant Thyroid Nodules.Patrick J Navin, Scott M Thompson, Anil N Kurup, Robert A Lee, Matthew R Callstrom
Radiographics. 2022-10-01
Journal Articles
- Sorafenib prolongs progression-free survival of metastatic thyroid cancer patientsCastro MR, Clinical Thyroidology for the Public, 9/1/2014
- Patients with Graves’ disease have a higher incidence of tall-cell variant of papillary thyroid carcinomaCastro MR, Clinical Thyroidology for the Public, 7/1/2014
- The incidence of second primary cancers is significantly higher than expected in patients with thyroid cancerCastro MR, Clinical Thyroidology for the Public, 4/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The value of repear FNA(rFNA)in thyroid nodules with a previously benign FNA: How often does the pathology change and does it make any difference?Sing Ospina N, Sebo TJ, Morris JC, Castro MR, Thyroid, 10/1/2014
- The utility of molecular markers in the preoperative evaluation of thyroid nodulesCastro MR, Mayo Clinic Endocrine Grand Rounds, 9/1/2014
- Thyroid Cancer in Solid Organ transplant recepientsGayatri J, Castro MR, Morris JC, Bernet V, Endocrine Society, 96th Annual Meeting, 6/1/2014
- Join now to see all
Committees
- Chair, Patient Affairs and Education Committee, ATA 2015 - Present
- Board of Directors, member, American Thyroid Association 2014 - 2018
- Board Liason, Clinical Affairs Committee, ATA 2014 - 2015
- Member, Trainees and career advancement committee, ATA 2010 - 2014
- Member, Editorial Board, Clinical Thyroidology for the Public, ATA 2006 - 2014
- Member, Patient Affairs and Education committee, ATA 2002 - 2014
Professional Memberships
- Member
- Member, Board of Directors
- Member
- Member
- Member
Other Languages
- Spanish, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: